Detalhe da pesquisa
1.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Cell
; 155(3): 531-9, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24243013
2.
Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model.
Proc Natl Acad Sci U S A
; 120(8): e2220415120, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787354
3.
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
; 119(24): e2202069119, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679343
4.
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
Proc Natl Acad Sci U S A
; 118(12)2021 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688035
5.
Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses.
PLoS Pathog
; 16(4): e1008505, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320436
6.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
J Infect Dis
; 218(4): 633-644, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669026
7.
Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
J Virol
; 91(19)2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28747505
8.
Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response.
J Virol
; 86(17): 9105-12, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22696658
9.
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice.
NPJ Vaccines
; 8(1): 47, 2023 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973267
10.
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
Sci Transl Med
; 15(716): eadg3540, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792954
11.
Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.
J Immunol
; 185(12): 7262-73, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21076059
12.
Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.
J Infect Dis
; 204(1): 164-73, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628671
13.
Interferon α/ß Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side Effects.
mBio
; 13(1): e0010222, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189701
14.
Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.
J Virol
; 84(16): 8172-80, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20519404
15.
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
Proc Natl Acad Sci U S A
; 105(31): 10889-94, 2008 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18678911
16.
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease.
bioRxiv
; 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33442693
17.
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.
J Virol
; 83(14): 7176-84, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19420086
18.
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Nature
; 428(6979): 182-5, 2004 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-15014500
19.
Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.
J Virol
; 82(16): 8022-9, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18524827
20.
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
J Virol
; 82(2): 652-63, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17977963